Literature DB >> 20105192

Clinical characteristics and mid-term outcomes of acute myocardial infarction patients with prior cerebrovascular disease in an Asian population: Lessons from the Korea Acute Myocardial Infarction Registry.

Yong-Jian Li1, Seung-Woon Rha, Kang-Yin Chen, Zhe Jin, Yoshiyasu Minami, Lin Wang, Qun Dang, Kanhaiya L Poddar, Sureshkumar Ramasamy, Ji-Young Park, Dong Joo Oh, Myung Ho Jeong.   

Abstract

1. The aim of the present study was to evaluated the impact of prior cerebrovascular disease (CVD) on the clinical characteristics and mid-term clinical outcomes of patients with acute myocardial infarction (AMI) in the era of drug-eluting stents. 2. Data from 12 914 patients with acute myocardial infarction who were enrolled in the Korea Acute Myocardial Infarction Registry were analysed retrospectively from November 2005 to December 2007. Prior CVD was defined as having had one or more events of ischaemic or haemorrhagic stroke or a transient ischaemic attack. 3. Of the 12 914 patients reviewed, 906 (7.0%) were found to have had prior CVD. Patients with CVD were older, were more likely to be women and were more likely to have hypertension and diabetes than those without CVD. Patients with prior CVD presented more often with non-ST-segment elevation myocardial infarction and higher Killip class than those without CVD. Furthermore, patients with CVD received less percutaneous coronary intervention (PCI) or thrombolysis compared with those without CVD. Although intensive medical therapy was equal in both groups, clinical outcomes at 8 months showed that patients with CVD had a higher incidence of cardiac death (adjusted odds ratio (OR) 1.42; 95% confidence interval (CI) 1.14-1.76; P = 0.002) and total death (adjusted OR 1.50; 95% CI 1.25-1.81; P < 0.001) than those without CVD. 4. In conclusion, patients with prior CVD presented with worse clinical characteristics on admission and were less likely to receive PCI or thrombolysis than those without CVD. Given the poorer mid-term clinical outcomes, more intensive and aggressive management shouldis recommended for patients with prior CVD to improve their long-term clinical outcome.

Entities:  

Mesh:

Year:  2010        PMID: 20105192     DOI: 10.1111/j.1440-1681.2010.05363.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  5 in total

1.  Outcomes After Percutaneous Coronary Intervention in Patients With a History of Cerebrovascular Disease: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.

Authors:  Chris Song; Devraj Sukul; Milan Seth; David Wohns; Simon R Dixon; Nicklaus K Slocum; Hitinder S Gurm
Journal:  Circ Cardiovasc Interv       Date:  2018-06       Impact factor: 6.546

2.  Time trend and age-period-cohort effects on acute myocardial infarction mortality in Korean adults from 1988 to 2007.

Authors:  Hyung-Joon Jhun; Ho Kim; Sung-Il Cho
Journal:  J Korean Med Sci       Date:  2011-04-21       Impact factor: 2.153

Review 3.  The scientific achievements of the decades in Korean Acute Myocardial Infarction Registry.

Authors:  Hyun Kuk Kim; Myung Ho Jeong; Seung Hun Lee; Doo Sun Sim; Young Joon Hong; Youngkeun Ahn; Chong Jin Kim; Myeong Chan Cho; Young Jo Kim
Journal:  Korean J Intern Med       Date:  2014-10-31       Impact factor: 2.884

4.  Effect of coronary artery revascularization on in-hospital outcomes and long-term prognoses in acute myocardial infarction patients with prior ischemic stroke.

Authors:  Bo-Yu Li; Xiao-Ming Li; Yan Zhang; Zhan-Yun Wei; Jing Li; Qi Hua
Journal:  J Geriatr Cardiol       Date:  2016-02       Impact factor: 3.327

5.  Novel insights into clinical characteristics and in-hospital outcomes of patients undergoing percutaneous coronary intervention in Vietnam.

Authors:  Hoa T T Vu; Hung M Pham; Hoai T T Nguyen; Quang N Nguyen; Loi D Do; Ngoc M Pham; Richard Norman; Rachel R Huxley; Crystal M Y Lee; Christopher M Reid
Journal:  Int J Cardiol Heart Vasc       Date:  2020-09-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.